Aardvark Therapeutics Appoints Timothy Kieffer as Chief Scientific Officer, Danny Villeneuve as Chief Commercial Officer, Terrie Kellmeyer as Senior Vice President, Regulatory Affairs and Christian Zapf as General Counsel.
Position
Chief Commercial Officer
Company
Aardvark Therapeutics
San DiegoManufacturingBiotechnologyDescription
Aardvark Therapeutics has selected multiple new executives to strengthen its management team. The company is bringing on acclaimed diabetes scientist Timothy Kieffer, PhD, as Chief Scientific Officer; Danny Villeneuve as Chief Commercial Officer; Terrie Kellmeyer, PhD, as Senior Vice President, Regulatory Affairs; and Christian Zapf, JD, as General Counsel.
Quick answer
Aardvark Therapeutics Appoints Timothy Kieffer as Chief Scientific Officer, Danny Villeneuve as Chief Commercial Officer, Terrie Kellmeyer as Senior Vice President, Regulatory Affairs and Christian Zapf as General Counsel. (May 23, 2025). Aardvark Therapeutics is based in San Diego, California, United States.
- Who is the new Chief Commercial Officer at Aardvark Therapeutics?
- Aardvark Therapeutics named Danny Villeneuve Chief Commercial Officer, announced May 23, 2025.
- What did Aardvark Therapeutics announce on May 23, 2025?
- Aardvark Therapeutics has selected multiple new executives to strengthen its management team. The company is bringing on acclaimed diabetes scientist Timothy Kieffer, PhD, as Chief Scientific Officer; Danny Villeneuve as Chief Commercial Officer; Terrie Kellmeyer, PhD, as Senior Vice President, Regulatory Affairs; and Christian Zapf, JD, as General Counsel.
- What does Aardvark Therapeutics do?
- Aardvark Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, inflammation,...
- Where is Aardvark Therapeutics based?
- Aardvark Therapeutics is based in San Diego, California, United States.
- Which similar companies made leadership changes around the same time?
- Ginkgo Bioworks (May 21, 2025), Zimmer (May 27, 2025), Elanco Animal Health (May 28, 2025) and Fotona (May 15, 2025) also announced leadership changes within 45 days of Aardvark Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Manufacturing and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Ginkgo Bioworks Appoints Steven Coen as Chief Financial Officer (May 21, 2025)
- Zimmer Biomet Appoints Kevin Thornal as Group President for Global Businesses and the Americas (May 27, 2025)
- Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer (May 28, 2025)
- Fotona Appoints Jeff Duchemin as Group President and CEO (May 15, 2025)
- PharmaLogic Appoints Etienne Montagut as President and Chief Executive Officer (June 2, 2025)
- Atlantic International Corp. Appoints Matt Evelt as Chief Operating Officer (June 2, 2025)
Who to call at Aardvark Therapeutics, and when
A new leader at Aardvark Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Aardvark Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aardvark Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aardvark Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aardvark Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aardvark Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.